Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Caputo

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Panminerva Medica|November 24, 2011
Effects of elastic compression on hypomobility edema and fibrinolysis activation in multiple sclerosisG Arpaia, P M Bavera, D Caputo, et al.
Neurology|September 26, 2008
Cognitive impairment and structural brain damage in benign multiple sclerosisM Rovaris, G Riccitelli, E Judica, et al.
Neurology|June 15, 2011
A multicenter assessment of cervical cord atrophy among MS clinical phenotypesM A Rocca, M A Horsfield, S Sala, et al.
Clinical Biochemistry|April 11, 2009
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescentsVanessa A Belo, Debora C Souza-Costa, Carla M Lana, et al.
AJNR. American Journal of Neuroradiology|November 15, 2011
Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approachK Kacar, M A Rocca, M Copetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosisP Ferrante, M L Fusi, M Saresella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 12, 2006
Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosisG Cavaletti, P Perseghin, M Dassi, et al.
Brain : a Journal of Neurology|August 22, 2006
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 yearsM Rovaris, E Judica, A Gallo, et al.
Proceedings (Baylor University. Medical Center)|July 9, 2011
Evaluation of the SEDline to improve the safety and efficiency of conscious sedationThomas D Caputo, Michael A E Ramsay, Jeffrey A Rossmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2011
Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapyM Chiarini, F Serana, C Zanotti, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Panminerva Medica|November 24, 2011
Effects of elastic compression on hypomobility edema and fibrinolysis activation in multiple sclerosisG Arpaia, P M Bavera, D Caputo, et al.
Neurology|September 26, 2008
Cognitive impairment and structural brain damage in benign multiple sclerosisM Rovaris, G Riccitelli, E Judica, et al.
Neurology|June 15, 2011
A multicenter assessment of cervical cord atrophy among MS clinical phenotypesM A Rocca, M A Horsfield, S Sala, et al.
Clinical Biochemistry|April 11, 2009
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescentsVanessa A Belo, Debora C Souza-Costa, Carla M Lana, et al.
AJNR. American Journal of Neuroradiology|November 15, 2011
Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approachK Kacar, M A Rocca, M Copetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosisP Ferrante, M L Fusi, M Saresella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 12, 2006
Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosisG Cavaletti, P Perseghin, M Dassi, et al.
Brain : a Journal of Neurology|August 22, 2006
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 yearsM Rovaris, E Judica, A Gallo, et al.
Proceedings (Baylor University. Medical Center)|July 9, 2011
Evaluation of the SEDline to improve the safety and efficiency of conscious sedationThomas D Caputo, Michael A E Ramsay, Jeffrey A Rossmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2011
Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapyM Chiarini, F Serana, C Zanotti, et al.
Pageof 17